UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Familial mesothelioma in first degree relatives

Diagnostic cytopathology, 2013-07, Vol.41 (7), p.654-657

2013

Volltextzugriff (PDF)

Association of insulin-like growth factor-1 receptor (IGF1R) expression in circulating tumor cells (CTCs) with E-cadherin (E-CAD) expression and improved survival in breast cancer (BC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23041-e23041

Agelaki, Sofia

2016

Volltextzugriff (PDF)

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

The lancet oncology, 2014-04, Vol.15 (4), p.406-414

2014

Volltextzugriff (PDF)

Third Harmonic Generation microscopy distinguishes malignant cell grade in human breast tissue biopsies

Scientific reports, 2020-07, Vol.10 (1), p.11055-11055, Article 11055

2020

Volltextzugriff (PDF)

Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

Molecular cancer therapeutics, 2019-02, Vol.18 (2), p.437-447

2019

Volltextzugriff (PDF)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer

International journal of molecular sciences, 2023-02, Vol.24 (3), p.2996

2023

Volltextzugriff (PDF)

Association of Ki-67 expression in CTCs with disease relapse in patients with early breast cancer (BC) and affect by the administration of adjuvant chemotherapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23243-e23243

2016

Volltextzugriff (PDF)

Circulating Biomarkers in Non-Small Cell Lung Cancer: Current Status and Future Challenges

Clinical lung cancer, 2016-11, Vol.17 (6), p.507-516

2016

Volltextzugriff (PDF)

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

PloS one, 2023-02, Vol.18 (2), p.e0277708-e0277708

2023

Volltextzugriff (PDF)

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

PloS one, 2021-06, Vol.16 (6), p.e0252537

2021

Volltextzugriff (PDF)

Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises

Expert review of molecular diagnostics, 2020-03, Vol.20 (3), p.335-344

2020

Volltextzugriff (PDF)

Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer

Cancers, 2022-03, Vol.14 (5), p.1314

2022

Volltextzugriff (PDF)

May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?

International journal of molecular sciences, 2022-12, Vol.24 (1), p.93

2022

Volltextzugriff (PDF)

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab

Cancers, 2022-09, Vol.14 (19), p.4739

2022

Volltextzugriff (PDF)

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

PloS one, 2023-11, Vol.18 (11), p.e0294382-e0294382

2023

Volltextzugriff (PDF)

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

PloS one, 2023-11, Vol.18 (11), p.e0294384-e0294384

2023

Volltextzugriff (PDF)

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

Breast cancer research : BCR, 2022-07, Vol.24 (1), p.1-53, Article 53

2022

Volltextzugriff (PDF)

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2177-2184

2009

Volltextzugriff (PDF)

The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach

NPJ primary care respiratory medicine, 2024-04, Vol.34 (1), p.5-9, Article 5

2024

Volltextzugriff (PDF)

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

International journal of molecular sciences, 2021-01, Vol.22 (2), p.925

2021

Volltextzugriff (PDF)

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211227-17588359221122728

2022

Volltextzugriff (PDF)

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting

Cancers, 2020-12, Vol.12 (12), p.3707

2020

Volltextzugriff (PDF)

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

Cancers, 2020-02, Vol.12 (2), p.376

2020

Volltextzugriff (PDF)

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Cancers, 2021-03, Vol.13 (7), p.1562

2021

Volltextzugriff (PDF)

Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review

Lung cancer (Amsterdam, Netherlands), 2019-09, Vol.135, p.29-32

2019

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(23)
Cancer Research
(12)
Cancers
(10)
Breast Cancer Research : Bcr
(7)
Plos One
(5)
Lung Cancer
(4)
Bmc Cancer
(3)
Cancer Chemotherapy And Pharmacology
(3)
Cells
(3)
Clinical Lung Cancer
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Familial mesothelioma in first degree relatives

Association of insulin-like growth factor-1 receptor (IGF1R) expression in circulating tumor cells (CTCs) with E-cadherin (E-CAD) expression and improved survival in breast cancer (BC)

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Third Harmonic Generation microscopy distinguishes malignant cell grade in human breast tissue biopsies

Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer

Association of Ki-67 expression in CTCs with disease relapse in patients with early breast cancer (BC) and affect by the administration of adjuvant chemotherapy

Circulating Biomarkers in Non-Small Cell Lung Cancer: Current Status and Future Challenges

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises

Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer

May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review

Suchergebnisse filtern